Clicky

Helix Biomedix Inc(HXBM)

Description: Helix BioMedix, Inc. is a specialty dermatology and consumer products skin health company, which is engaged in developing bioactive peptides for uses across a range of markets. The Company focuses on developing topically-applied products, which offer the health, beauty and safety benefits of its bioactive small molecule technology. The Company is engaged in developing topical anti-infectives for the treatment of skin and wound infections, and the prevention of Staphylococcus aureus (S. aureus) infections, including those caused by Methicillin-resistant Staphylococcus aureus (MRSA). The Company's programs are based upon a family of molecules known as lipohexapeptides (or small molecule peptides) that it has developed to specifically combine the attributes of small molecule natural products with the advantages of antimicrobial peptides. The Company's lipohexapeptides (HB1345 and HB1275) do not exhibit cross-resistance with other antibiotics.


Keywords: Medicine Antibiotics E Health Dermatology Microbiology Peptides Bacteria Anti Infectives Antimicrobial Molecules Staphylococcus Aureus Natural Products Loco Natural Product Gram Positive Bacteria Methicillin Bioactive Helix Antimicrobial Peptides Ipoh S. Aureus Staphylococcaceae Staphylococcus

Home Page: www.helixbiomedix.com

22121-17th Avenue SE
Bothell, WA 98021
United States
Phone: 425-402-8400


Officers

Name Title
Ms. Robin L. Carmichael Pres, CEO & Director
Kelly Forsythe Associate Director of Marketing

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.3231
Price-to-Sales TTM: 2.8075
IPO Date:
Fiscal Year End: December
Full Time Employees: 8
Back to stocks